Benzinga··Vandana SinghMeiraGTx Reacquires Eye Disease Drug From J&J for $25M, Eyes 2027 Launch
MeiraGTx reacquires J&J's eye disease drug bota-vec for $25M, raises $100M in funding, targeting 2027 launch. Stock falls 15.8%.
JNJLLYMGTXcapital raiseregulatory approval